1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Biological Therapy Analysis & Statistics, March 2016 (p20)

Biological Therapy Analysis & Statistics, March 2016 (p20)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publishers

571-600 of about 1100 reports

Purchase Reports From Reputable Market Research Publishers

Global Immunotherapy Drugs 2016-2020

Global Immunotherapy Drugs 2016-2020

  • $ 2500
  • Industry report
  • March 2016
  • by Infiniti Research Limited

About Immunotherapy Drugs Immunotherapy enhances the innate powers of the immune system. The properties of the immune system to fight abnormal cells give immunotherapy drugs the chance of successfully ...

  • Industries : Biological Therapy
  • Countries : United States, World
Furfuryl Alcohol Market: By Cell Type (T-Cell and B-Cell); By Treatment Type (Radiation therapy, Mild Chemotherapies, Topical Treatments, and Biological Therapies); By Method of Diagonization and By Geography-Forecast (2016-2021)

Furfuryl Alcohol Market: By Cell Type (T-Cell and B-Cell); By Treatment Type (Radiation therapy, Mild Chemotherapies, Topical Treatments, and Biological Therapies); By Method of Diagonization and By Geography-Forecast (2016-2021)

  • $ 5250
  • Industry report
  • March 2016
  • by Industry ARC

Furfuryl alcohol is an organic compound manufactured by catalytic reduction of furfuran. The raw material furfuran is obtained from sugarcane bagasse, corn cobs, wheat bran and oats among others. It has ...

  • Industries : Biological Therapy
  • Countries : World
Nuclear Medicine/Radiopharmaceutical Global Market  – Forecast To 2022

Nuclear Medicine/Radiopharmaceutical Global Market – Forecast To 2022

  • $ 4500
  • Industry report
  • March 2016
  • by IQ4I Research & Consultancy Pvt. Ltd

Way back to the history, over the past 50 years nuclear medicine sector has displayed a strong link between investments in chemistry and development of radionuclide’s and radiolabeled compounds. This ...

  • Industries : General Medicine and Specialty Medicine, Healthcare
  • Countries : World
Osteoarthritis - Pipeline Review, H1 2016

Osteoarthritis - Pipeline Review, H1 2016

  • $ 2000
  • Company report
  • March 2016
  • by Global Markets Direct

Osteoarthritis - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Osteoarthritis - Pipeline Review, H1 2016’, provides an overview of the Osteoarthritis pipeline landscape. The report provides ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States
Nasopharyngeal Cancer - Pipeline Review, H1 2016

Nasopharyngeal Cancer - Pipeline Review, H1 2016

  • $ 2000
  • Company report
  • March 2016
  • by Global Markets Direct

Nasopharyngeal Cancer - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Nasopharyngeal Cancer - Pipeline Review, H1 2016’, provides an overview of the Nasopharyngeal Cancer pipeline landscape. ...

  • Industries : Cancer, Pathology
  • Countries : United States
Thalassemia - Pipeline Review, H1 2016

Thalassemia - Pipeline Review, H1 2016

  • $ 2000
  • Company report
  • March 2016
  • by Global Markets Direct

Thalassemia - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Thalassemia - Pipeline Review, H1 2016’, provides an overview of the Thalassemia pipeline landscape. The report provides comprehensive ...

  • Industries : Pathology
  • Countries : United States
Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H1 2016

Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H1 2016

  • $ 2000
  • Company report
  • March 2016
  • by Global Markets Direct

Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H1 2016’, provides ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Healthcare
  • Countries : United States
Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2016

Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2016

  • $ 2000
  • Company report
  • March 2016
  • by Global Markets Direct

Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2016’, provides an overview of ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States
2016-2020 Future Horizons and Growth Strategies in the Global Cell Surface Testing Market: Supplier Shares, Competitive Intelligence, Emerging Opportunities

2016-2020 Future Horizons and Growth Strategies in the Global Cell Surface Testing Market: Supplier Shares, Competitive Intelligence, Emerging Opportunities

  • $ 3500
  • Industry report
  • March 2016
  • by Venture Planning Group

The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic ...

  • Industries : Biological Therapy
2016-2020 Future Horizons and Growth Strategies in the US Cell Surface Marker Testing Market: Supplier Shares, Competitive Intelligence, Emerging Opportunities

2016-2020 Future Horizons and Growth Strategies in the US Cell Surface Marker Testing Market: Supplier Shares, Competitive Intelligence, Emerging Opportunities

  • $ 1450
  • Industry report
  • March 2016
  • by Venture Planning Group

Complete report $2,250.  DataPack (test volumes, sales forecasts, supplier shares) $1,450. Rationale The use of surface marker identification and classification of cells is spreading beyond lymphocytes ...

  • Industries : Biological Therapy
  • Countries : United States
Global 3D Cell Culture Industry 2016 Market Research Report

Global 3D Cell Culture Industry 2016 Market Research Report

  • $ 2850
  • Industry report
  • March 2016
  • by 9Dimen Research

2016 Global 3D Cell Culture Industry Report is a professional and in-depth research report on the world's major regional market conditions of the 3D Cell Culture industry, focusing on the main regions ...

  • Industries : Biological Therapy, In Vitro Diagnostics
  • Countries : World, Europe, Asia, North America
Global Biotherapeutics Industry 2016 Market Research Report

Global Biotherapeutics Industry 2016 Market Research Report

  • $ 2850
  • Industry report
  • March 2016
  • by 9Dimen Research

2016 Global Biotherapeutics Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Biotherapeutics industry, focusing on the main regions ...

  • Industries : Biological Therapy
  • Countries : World, Europe, Asia, North America
Therapy Industry Forecasts - China Focus

Therapy Industry Forecasts - China Focus

  • $ 1000
  • Industry report
  • March 2016
  • by Asia Market Information & Development Company

This study focuses on China’s Therapy industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising ...

  • Industries : Therapy
  • Countries : China
2016-2020 Emerging Opportunities in the Cell Surface Markers: US, Europe (France, Germany, Italy, Spain, UK), Japan--Emerging Opportunities, Country Forecasts, Innovative Technologies, and Competitive Landscape

2016-2020 Emerging Opportunities in the Cell Surface Markers: US, Europe (France, Germany, Italy, Spain, UK), Japan--Emerging Opportunities, Country Forecasts, Innovative Technologies, and Competitive Landscape

  • $ 3500
  • Industry report
  • March 2016
  • by Venture Planning Group

The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic ...

  • Industries : Biological Therapy
  • Countries : United States, Spain, France, Italy, United Kingdom, Japan
2016-2020 Emerging US Cell Surface Marker Testing Market: Hospitals, Commercial Labs, Ambulatory Care Centers, Physician Offices--Emerging Opportunities for Instrument and Reagent Suppliers--Competitive Strategies, Country Volume and Sales Segment Forecas

2016-2020 Emerging US Cell Surface Marker Testing Market: Hospitals, Commercial Labs, Ambulatory Care Centers, Physician Offices--Emerging Opportunities for Instrument and Reagent Suppliers--Competitive Strategies, Country Volume and Sales Segment Forecas

  • $ 1450
  • Industry report
  • March 2016
  • by Venture Planning Group

Complete report $2,250.  DataPack (test volumes, sales forecasts, supplier shares) $1,450. Rationale The use of surface marker identification and classification of cells is spreading beyond lymphocytes ...

  • Industries : Biological Therapy
  • Countries : United States
Micro-RNA Market: By Tool (Microarrays, NGS, qRT-PCR, Northern Blotting, ISH), By End-User (Biotech Companies, Academic, Research Institutes) & By Geography -Forecast (2016-2021)

Micro-RNA Market: By Tool (Microarrays, NGS, qRT-PCR, Northern Blotting, ISH), By End-User (Biotech Companies, Academic, Research Institutes) & By Geography -Forecast (2016-2021)

  • $ 5250
  • Industry report
  • March 2016
  • by Industry ARC

MicroRNA, also known as miRNA, is a class of non-coding ribonucleic acid (RNA) which plays a vital role in the regulation of gene expression and also involved in RNA silencing. It is found in animals, ...

  • Industries : Biological Therapy
Plasticell, Ltd. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Plasticell, Ltd. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Countries : United Kingdom
Embryome Sciences, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Embryome Sciences, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biological Therapy
  • Countries : United States
iPS Academia Japan, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

iPS Academia Japan, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biological Therapy
  • Countries : Japan
InteRNA Technologies B.V. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

InteRNA Technologies B.V. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biological Therapy
  • Countries : United Kingdom, United States
Aruna Biomedical, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Aruna Biomedical, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Countries : United States, United Kingdom
BioTime, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

BioTime, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biological Therapy
  • Countries : United States
Genova Biotherapeutics, Inc. (formerly Kinder Travel, Inc.) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Genova Biotherapeutics, Inc. (formerly Kinder Travel, Inc.) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Countries : United Kingdom
Stemgent, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Stemgent, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Countries : United States
CHA Bio & Diostech Co., Ltd. (formerly CHA Biotech, Co., Ltd.) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

CHA Bio & Diostech Co., Ltd. (formerly CHA Biotech, Co., Ltd.) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Countries : South Korea
Oxford BioTherapeutics, Ltd. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Oxford BioTherapeutics, Ltd. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Countries : United States
Cord Blood America, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Cord Blood America, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Blood Supply, Tissue Banking and Transplantation, Biological Therapy
  • Countries : United States
Bio-Matrix Scientific Group, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Bio-Matrix Scientific Group, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Countries : United States
Juvaris BioTherapeutics, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Juvaris BioTherapeutics, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Countries : United Kingdom, United States
Lifeline Cell Technology, LLC – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Lifeline Cell Technology, LLC – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biological Therapy
  • Countries : United States
About 3600 reports

Download Unlimited Documents from Trusted Public Sources

Biological Therapy Industry in the US

  • January 2017
    7 pages
  • Biological Ther...  

  • United States  

View report >

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.